| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 24.182 | 23.837 | 20.369 | 23.615 | 22.343 | 26.201 | 27.579 | 27.023 | - | - |
| Total Income - EUR | 24.182 | 23.838 | 20.370 | 23.616 | 22.344 | 26.204 | 27.581 | 27.025 | - | - |
| Total Expenses - EUR | 10.827 | 9.277 | 8.656 | 7.713 | 9.678 | 8.090 | 12.205 | 13.433 | - | - |
| Gross Profit/Loss - EUR | 13.355 | 14.562 | 11.714 | 15.903 | 12.666 | 18.113 | 15.377 | 13.592 | - | - |
| Net Profit/Loss - EUR | 12.630 | 13.850 | 11.103 | 15.195 | 11.996 | 17.354 | 14.960 | 12.798 | - | - |
| Employees | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | - | - |
Check the financial reports for the company - Diabet Med S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 2.863 | 2.716 | 2.554 | 2.393 | 3.052 | 2.617 | 2.190 | 2.700 | - | - |
| Current Assets | 10.636 | 13.868 | 11.742 | 13.449 | 13.953 | 25.991 | 30.706 | 27.058 | - | - |
| Inventories | 0 | 0 | 71 | 70 | 68 | 67 | 66 | 0 | - | - |
| Receivables | 20 | 154 | 20 | 19 | 19 | 571 | 2.082 | 574 | - | - |
| Cash | 10.616 | 13.714 | 11.651 | 13.360 | 13.866 | 25.352 | 28.557 | 26.484 | - | - |
| Shareholders Funds | 12.684 | 13.902 | 11.198 | 15.246 | 16.411 | 27.795 | 31.991 | 12.848 | - | - |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | - | - |
| Debts | 816 | 2.681 | 3.097 | 595 | 594 | 812 | 904 | 16.910 | - | - |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - | - |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Diabet Med S.r.l.